Dr. Dipanjan Banerjee MD

About Dr. Banerjee

EDUCATION

• Advanced Fellowship, Heart Failure/Transplant & Preventive Cardiology — Stanford University (2009–2010)
• Fellowship, Cardiovascular Medicine — Stanford University (2006–2010)
• Internship & Residency, Internal Medicine — Stanford University (2002–2005)
• MS, Clinical Epidemiology — Stanford University (2008–2010)
• MD, University of Missouri School of Medicine (summa cum laude) (1998–2002)
• AB, English — Harvard University (magna cum laude) (1994–1998)

WORK EXPERIENCE

• Advanced Heart Failure Cardiologist, Ohana Heart LLC (Feb 2025–Present)
• Advanced Heart Failure Cardiologist, Pacific Cardiology (2024–Present)
• Professor of Medicine, University of Hawaii (2023–Present)
• Director, Heart Failure Program & Inpatient Cardiovascular Services, The Queen’s Medical Center (2019–2023)
• Built Hawaii’s first comprehensive heart failure program
• Led CCU to 90th percentile national performance
• Medical Director, LVAD Program, Stanford Health Care (2010–2019)
• Grew to highest-volume LVAD program on West Coast
• Reduced 30-day HF readmissions from 21% to 14% (> $3M cost savings)
• Board Certifications: Cardiovascular Disease; Advanced Heart Failure/Transplant Cardiology; Internal Medicine
• Clinical Expertise: Cardiogenic shock, mechanical circulatory support (LVAD), transplant cardiology, echocardiography, invasive non-interventional cardiology

PUBLICATIONS & SCHOLARSHIP

• Author of 60+ peer-reviewed publications in leading cardiovascular journals (e.g., JAMA, JACC, Circulation: Heart Failure)
• Principal Investigator and Site PI on multiple NHLBI- and industry-sponsored multicenter clinical trials
• National and international invited speaker in advanced heart failure and mechanical circulatory support
• Editorial board member and ad hoc reviewer for major cardiology journals